ロード中...
Rationale for Eliminating Staphylococcus Breakpoints for β-Lactam Agents Other Than Penicillin, Oxacillin or Cefoxitin, and Ceftaroline
Due to the ongoing concern about the reliability of Staphylococcus breakpoints (interpretive criteria) for other β-lactam agents, the Clinical and Laboratory Standards Institute recently approved the elimination of all breakpoints for antistaphylococcal β-lactams except for penicillin, oxacillin or...
保存先:
| 出版年: | Clin Infect Dis |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5734619/ https://ncbi.nlm.nih.gov/pubmed/24457339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu043 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|